Biotech ETF Industry Outlook for Second Half 2017
July 25, 2017 at 06:30 AM EDT
R&D success and innovation, strong results, a higher number of FDA approvals and continued strong performance from legacy products are some of the factors that could contribute to a sustained recovery in the biotech sector.
